Healio Among 49 studies, including 23 assessing lamivudine (LAM), 16, adefovir (ADV); and 10 of either entecavir (ETV), tenofovir (TDF) or telbivudine (TBV) in 10,025 patients, the pooled HCC incidence rate was 1.3 cases per 100 person-years. Significant ...
Healio ... Clinical Practice,” Nguyen and colleagues evaluated the effectiveness of four oral therapies for HBV in a large, real world-cohort. They found that first-line agents tenofovir and entecavir were more effective than older medications lamivudine and ...
